Opinionated, data-backed coverage across all asset classes

India's five office REITs are expanding through acquisitions and new construction. Bagmane Prime has a 47M sq ft pipeline; Embassy signed 1.3M sq ft in Q1 leases. Combined market cap crossed ₹2.17 lakh crore.

Peter England, BIBA and Libas launch youth sub-brands while Trent and ABFRL build standalone formats. Early data shows 85% sales growth at Libas's Gerua.

Smartphone prices up 15%, TVs up 17%. Retailers expect 8-10% festive growth but price-sensitive buyers may slow. Premiumization and EMI financing offset some risk.

The most urgent airdrop deadline this week: GRVT's first tranche expires at the end of August. Propr launches August 24. Plume and dappOS lack published deadlines. Grass has until January 2027.

YouTube is in early talks to pay top creators millions for exclusive content, a direct response to Netflix's push into creator licensing and video podcasts.

Tivan pays $125k upfront, funds $75k exploration, can exercise option by June 2027 for $500k in cash and shares. Existing assays show up to 0.76% copper and 9.3 g/t gold.

Bitvavo's Bitcoin withdrawal fee ran 8-16 times the network cost on Aug 17, 2026. Median fee across 429 assets: €0.84. Withdrawal status can change without notice; check before moving funds.

Memory chip prices have quadrupled since Sept 2025, forcing Chinese phone makers to raise prices and pushing cost-conscious Indian buyers toward premium brands like Apple and Samsung.

AWS is expanding its Builder Loft program to Hyderabad, Berlin and São Paulo, giving developers free workshops, co-working and networking spaces.

Japan's exports surged 23.2% in July, beating forecasts, as semiconductor equipment shipments jumped 49% on AI demand. But the Iran war pushed petroleum import costs up 87.8%.

India, Japan, South Korea and China are investing billions in hydrogen-powered trains, using rail as a demand anchor for a green hydrogen economy even as the technology remains years from commercial scale.

Trump picks White House aide Heidi Overton for FDA commissioner, setting up Senate fights over vaccine policy, abortion pill access, and industry regulation.